D. Boral Capital initiated coverage on Scilex Holding with a new price target
$SCLX
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
D. Boral Capital initiated coverage of Scilex Holding with a rating of Buy and set a new price target of $22.00